Improved mesenchymal stem cell survival in ischemic heart through electroacupuncture

Area of Science:

• Regenerative Medicine
• Cardiovascular Research
• Stem Cell Biology

Background:

• Mesenchymal stem cells (MSCs) show therapeutic potential for ischemic heart disease.
• Optimizing MSC survival and function is crucial for effective stem cell therapy.
• Electroacupuncture (EA) is a potential adjunct therapy to enhance MSC efficacy.

Purpose of the Study:

• To determine if EA can improve the survival of transplanted MSCs.
• To assess the impact of EA on cardiac function following myocardial infarction (MI).
• To investigate EA's role in enhancing MSC-based therapy for ischemic hearts.

Main Methods:

• MSCs were isolated and expanded.
• Myocardial infarction was induced in Sprague-Dawley rats.
• Rats received MSCs alone, MSCs plus EA, or saline, with a sham group for comparison.
• MSC survival, gene expression, cardiac function, infarct size, fibrosis, and capillary density were analyzed.

Main Results:

• EA significantly increased MSC survival by 2.6-fold at day 4.
• EA treatment led to a 53% increase in capillary density compared to MSCs alone.
• EA reduced fibrosis and infarct size by 36%, improving cardiac function and reducing ventricular remodeling.

Conclusions:

• EA at the Neiguan (PC6) acupoint enhances MSC survival and cardiac function in ischemic hearts.
• EA represents a promising adjunctive therapy to improve outcomes in stem cell therapy for heart disease.
• This study supports EA as a valuable approach for ischemic heart disease treatment using stem cells.